Risankizumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14762 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 54 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | dermatitis | KG + DL |
| 2 | neonatal dermatomyositis | KG + DL |
| 3 | amyopathic dermatomyositis | KG + DL |
| 4 | acrodermatitis chronica atrophicans | KG + DL |
| 5 | acne keloid | KG + DL |
| 6 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 7 | hydroa vacciniforme, familial | KG + DL |
| 8 | severe nonproliferative diabetic retinopathy | KG + DL |
| 9 | pityriasis lichenoides | KG + DL |
| 10 | acute lichenoid pityriasis | KG + DL |
| 11 | diabetic retinopathy | KG + DL |
| 12 | pustulosis palmaris et plantaris | KG + DL |
| 13 | psoriasis 14, pustular | KG + DL |
| 14 | primary release disorder of platelets | KG + DL |
| 15 | pseudo-von Willebrand disease | KG + DL |
| 16 | seborrheic dermatitis | KG + DL |
| 17 | neurolymphomatosis | KG + DL |
| 18 | polyp of middle ear | KG + DL |
| 19 | polyp of vocal cord | KG + DL |
| 20 | plasmacytoma | KG + DL |
| 21 | epulis | KG + DL |
| 22 | polyp of ureter | KG + DL |
| 23 | polyp of frontal sinus | KG + DL |
| 24 | polyp of external auditory canal | KG + DL |
| 25 | uterine polyp | KG + DL |
| 26 | polyp of vulva | KG + DL |
| 27 | fibroepithelial polyp | KG + DL |
| 28 | neoplastic polyp | KG + DL |
| 29 | Glanzmann thrombasthenia | KG + DL |
| 30 | candidiasis, familial | KG + DL |
| 31 | Crohn’s colitis | KG + DL |
| 32 | penile fibromatosis | KG + DL |
| 33 | infantile digital fibromatosis | KG + DL |
| 34 | Ledderhose disease | KG + DL |
| 35 | palmar fibromatosis | KG + DL |
| 36 | diabetic cataract | KG + DL |
| 37 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 38 | generalized pustular psoriasis | KG + DL |
| 39 | posterior leukoencephalopathy syndrome | KG + DL |
| 40 | dry eye syndrome | KG + DL |
| 41 | severe dermatitis-multiple allergies-metabolic wasting syndrome | KG + DL |
| 42 | psoriasis 2 | KG + DL |
| 43 | drug-induced osteoporosis | KG + DL |
| 44 | pityriasis simplex | KG + DL |
| 45 | cholestasis | KG + DL |
| 46 | nasal cavity polyp | KG + DL |
| 47 | lipoid nephrosis | KG + DL |
| 48 | familial Dupuytren contracture | KG + DL |
| 49 | non-syndromic visceral malformation | KG + DL |
| 50 | gout | KG + DL |
(Showing top 50 of 54 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.